---
figid: PMC4216608__nihms628688f1
figtitle: Metabolism and bioactivation of carcinogenic aromatic and heterocyclic amines
organisms:
- Homo sapiens
- Rattus norvegicus
- Nicotiana tabacum
- Actinobacillus minor
- Glires
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4216608
filename: nihms628688f1.jpg
figlink: /pmc/articles/PMC4216608/figure/F1/
number: F1
caption: Metabolism and bioactivation of carcinogenic aromatic and heterocyclic amines.
  Aromatic and heterocyclic amines may initially be detoxified by either glucuronidation
  or N-acetylation (by NAT1 or NAT2). Alternatively, the parent amines can be bioactivated
  to their hydroxylamine metabolites via cytochrome P450′s (CYP1A2, 1A1, and 1B1),
  myeloperoxidases, or lactoperoxidases. Hydroxylamine metabolites are reduced back
  to their parent compound by NADH cytochrome b5 reductase (b5R) and cytochrome b5
  (b5) []. Reverse reduction by the b5/b5R pathway is up to 55 times more efficient
  than forward oxidation by P450′s []. Hydroxylamine metabolites may also be detoxified
  by glutathione S-transferases (GST′s) or UDP-glucuronosyltransferases (UGT's), or
  can be further bioactivated by O-acetylation or O-sulfonation. This final bioactivation
  step can lead to DNA adducts via arylnitrenium ion formation.
papertitle: Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3
  and breast cancer risk in African American women.
reftext: Kristina L. Blanke, et al. Cancer Causes Control. ;25(11):1513-1521.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8816965
figid_alias: PMC4216608__F1
figtype: Figure
redirect_from: /figures/PMC4216608__F1
ndex: 24a9d055-df14-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4216608__nihms628688f1.html
  '@type': Dataset
  description: Metabolism and bioactivation of carcinogenic aromatic and heterocyclic
    amines. Aromatic and heterocyclic amines may initially be detoxified by either
    glucuronidation or N-acetylation (by NAT1 or NAT2). Alternatively, the parent
    amines can be bioactivated to their hydroxylamine metabolites via cytochrome P450′s
    (CYP1A2, 1A1, and 1B1), myeloperoxidases, or lactoperoxidases. Hydroxylamine metabolites
    are reduced back to their parent compound by NADH cytochrome b5 reductase (b5R)
    and cytochrome b5 (b5) []. Reverse reduction by the b5/b5R pathway is up to 55
    times more efficient than forward oxidation by P450′s []. Hydroxylamine metabolites
    may also be detoxified by glutathione S-transferases (GST′s) or UDP-glucuronosyltransferases
    (UGT's), or can be further bioactivated by O-acetylation or O-sulfonation. This
    final bioactivation step can lead to DNA adducts via arylnitrenium ion formation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PHIP
  - TUBB4A
  - HPGDS
  - SLCO6A1
  - GSTK1
  - GSTA1
  - GSTA2
  - GSTA3
  - GSTA4
  - GSTA5
  - GSTM1
  - GSTM2
  - GSTM3
  - GSTM4
  - GSTM5
  - GSTO1
  - GSTO2
  - GSTP1
  - GSTT1
  - GSTT2
  - GSTZ1
  - GSTT2B
  - SLC35A2
  - UGT1A
  - UGT1A1
  - UGT1A2P
  - UGT1A3
  - UGT1A4
  - UGT1A5
  - UGT1A6
  - UGT1A7
  - UGT1A8
  - UGT1A9
  - UGT1A10
  - UGT1A11P
  - UGT1A12P
  - UGT1A13P
  - UGT2A1
  - UGT2A2
  - UGT2A3
  - UGT2B4
  - UGT2B7
  - UGT2B10
  - UGT2B11
  - UGT2B15
  - UGT2B17
  - UGT2B24P
  - UGT2B25P
  - UGT2B26P
  - UGT2B27P
  - UGT2B28
  - UGT2B29P
  - UGT3A1
  - UGT3A2
  - UGT8
  - Prosbeta5
  - GstS1
  - GstE12
  - GstD1
  - GstD2
  - GstD3
  - GstD4
  - GstD5
  - GstD6
  - GstD7
  - GstD8
  - Ugalt
  - Uggt
  - 4-aminobiphenyl
  - Hydroxylamine
---
